Skip to main content
Top
Published in: Journal of Neurology 4/2015

Open Access 01-04-2015 | Short Commentary

Can MS lesion stages be distinguished with MRI? A postmortem MRI and histopathology study

Authors: Laura E. Jonkman, Alexandra Lopez Soriano, Sandra Amor, Frederik Barkhof, Paul van der Valk, Hugo Vrenken, Jeroen J. G. Geurts

Published in: Journal of Neurology | Issue 4/2015

Login to get access

Abstract

In multiple sclerosis (MS), a histopathological distinction is made between different stages of white matter (WM) lesions. These lesions are characterized as preactive, active, chronic active or chronic inactive, depending on the degree of microglia activation and degree of demyelination. The different lesions are not distinguishable on conventional magnetic resonance imaging (MRI) scans at standard clinical field strengths, but might be distinguished using more advanced, quantitative MRI methods, such as T1 relaxation time (T1-RT) mapping. To investigate this, postmortem brain material from 20 MS patients was investigated, using both T1-RT MRI at 1.5T and histopathology. The brain material contained a total of 9 preactive, 18 active, 30 chronic active and 14 chronic inactive lesions, as well as 38 areas of normal appearing WM (NAWM). Our results show that, at 1.5T, T1-RT qMRI can only distinguish between categories NAWM/preactive, active and chronic WM lesions. Advanced imaging at standard field strengths, such as conventional imaging measures, is therefore insufficient to differentiate the WM lesions in MS, and higher field strengths may be required to achieve better pathological differentiation of these lesions.
Literature
1.
go back to reference van der Valk P, De Groot CJ (2000) Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 26(1):2–10CrossRefPubMed van der Valk P, De Groot CJ (2000) Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 26(1):2–10CrossRefPubMed
2.
go back to reference McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127CrossRefPubMed McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127CrossRefPubMed
3.
go back to reference Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58(6):840–846CrossRefPubMed Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58(6):840–846CrossRefPubMed
4.
go back to reference Vrenken H, Geurts JJG, Knol DL, Polman CH, Castelijns JA, Pouwels PJW et al (2006) Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. AJNR 27(9):2005–2011PubMed Vrenken H, Geurts JJG, Knol DL, Polman CH, Castelijns JA, Pouwels PJW et al (2006) Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. AJNR 27(9):2005–2011PubMed
5.
go back to reference Vrenken H, Seewann A, Knol DL, Polman CH, Barkhof F, Geurts JJG (2010) Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types. AJNR 31(3):541–548CrossRefPubMed Vrenken H, Seewann A, Knol DL, Polman CH, Barkhof F, Geurts JJG (2010) Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types. AJNR 31(3):541–548CrossRefPubMed
6.
go back to reference Neema M, Stankiewicz J, Arora A, Dandamudi VSR, Batt CE, Guss ZD et al (2007) T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging 17(Suppl 1):16S–21SCrossRefPubMed Neema M, Stankiewicz J, Arora A, Dandamudi VSR, Batt CE, Guss ZD et al (2007) T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging 17(Suppl 1):16S–21SCrossRefPubMed
7.
go back to reference Schmierer K, Wheeler-Kingshott CAM, Tozer DJ, Boulby PA, Parkes HG, Yousry TA et al (2008) Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation. Magn Reson Med 59(2):268–277PubMedCentralCrossRefPubMed Schmierer K, Wheeler-Kingshott CAM, Tozer DJ, Boulby PA, Parkes HG, Yousry TA et al (2008) Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation. Magn Reson Med 59(2):268–277PubMedCentralCrossRefPubMed
8.
go back to reference Van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R et al (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46(5):747–754CrossRefPubMed Van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R et al (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46(5):747–754CrossRefPubMed
9.
go back to reference Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH (2004) Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 56(3):407–415CrossRefPubMed Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH (2004) Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 56(3):407–415CrossRefPubMed
10.
go back to reference Mostert JP, Koch MW, Steen C, Heersema DJ, De Groot JC, De Keyser J (2010) T2 lesions and rate of progression of disability in multiple sclerosis. Eur J Neurol 17(12):1471–1475CrossRefPubMed Mostert JP, Koch MW, Steen C, Heersema DJ, De Groot JC, De Keyser J (2010) T2 lesions and rate of progression of disability in multiple sclerosis. Eur J Neurol 17(12):1471–1475CrossRefPubMed
11.
go back to reference Seewann A, Kooi E-J, Roosendaal SD, Barkhof F, van der Valk P, Geurts JJG (2009) Translating pathology in multiple sclerosis: the combination of postmortem imaging, histopathology and clinical findings. Acta Neurol Scand 119(6):349–355CrossRefPubMed Seewann A, Kooi E-J, Roosendaal SD, Barkhof F, van der Valk P, Geurts JJG (2009) Translating pathology in multiple sclerosis: the combination of postmortem imaging, histopathology and clinical findings. Acta Neurol Scand 119(6):349–355CrossRefPubMed
12.
go back to reference Bö L, Geurts JJG, Ravid R, Barkhof F (2004) Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis. Neuropathol Appl Neurobiol 30(2):106–117CrossRefPubMed Bö L, Geurts JJG, Ravid R, Barkhof F (2004) Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis. Neuropathol Appl Neurobiol 30(2):106–117CrossRefPubMed
13.
go back to reference Venkatesan R, Lin W, Haacke EM (1998) Accurate determination of spin-density and T1 in the presence of RF-field inhomogeneities and flip-angle miscalibration. Magn Reson Med 40(4):592–602CrossRefPubMed Venkatesan R, Lin W, Haacke EM (1998) Accurate determination of spin-density and T1 in the presence of RF-field inhomogeneities and flip-angle miscalibration. Magn Reson Med 40(4):592–602CrossRefPubMed
14.
go back to reference Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47(6):707–717CrossRefPubMed Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47(6):707–717CrossRefPubMed
15.
go back to reference Lucchinetti C (2008) Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders. Curr Top Microbiol Immunol 318:19–43PubMed Lucchinetti C (2008) Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders. Curr Top Microbiol Immunol 318:19–43PubMed
Metadata
Title
Can MS lesion stages be distinguished with MRI? A postmortem MRI and histopathology study
Authors
Laura E. Jonkman
Alexandra Lopez Soriano
Sandra Amor
Frederik Barkhof
Paul van der Valk
Hugo Vrenken
Jeroen J. G. Geurts
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 4/2015
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7689-4

Other articles of this Issue 4/2015

Journal of Neurology 4/2015 Go to the issue